B Cell Responses to CpG Correlate with CXCL16 Expression Levels in Common Variable Immunodeficiency
Figure 3
Defective upregulation of activation markers (CD69, CD86) after in vitro stimulation with CpG in CVID. (a) Fold increase in CD69 expression in healthy controls and CVID patients CVID (mean of six and fifteen samples, resp.). (b) Fold increase in CD86 expression in healthy controls and CVID patients (mean of six and fifteen samples, resp.). Graph bars show standard error (SE).
